跳至主要内容
临床试验/NL-OMON52709
NL-OMON52709已完成不适用

Optimalisation of exocrine pancreatic insufficiency and pancreatic enzyme replacement therapy. - OPPERT-study

Vrije Universiteit Medisch Centrum0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1) Age * 18 years;
  • 2) Written informed consent;
  • 3) Understanding of the Dutch language;
  • 4) Willing and capable of following the instructions for this study;
  • 5) Patients need to be able to achieve a minimal daily dietary fat intake of *

排除标准

  • 1) Any known gastrointestinal disease or major gastrointestinal surgery (apart
  • from a PD, esophagectomy, gastrectomy) that could potentially affect the
  • intestinal absorption or metabolism of fat (e.g. short bowel, irritable bowel
  • disease, cystic fibrosis, chronic pancreatitis among others).
  • 2) Gastroparesis of any aetiology (not applicable for group III and IV) .
  • 3) Serious concomitant systemic disorders that would compromise the safety of
  • the patient or his/her ability to complete the study, at the discretion of the
  • treating physician.
  • 4) Patients who are unable to cease anti-diarrheal medication or laxatives,
  • based on the physician*s experience.
  • 5) Patients who are suspected not to be reliable in participating in this
  • study, based on the physician*s experience.

研究者

相似试验